Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Graft Versus Host Disease
Related studies linked through entity extraction aliases.
Romidepsin in Treating Patients With Steroid-Refractory Graft-versus-Host Disease
- Status
- TERMINATED
- Phase
- NA
Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Chronic Graft Versus Host Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression
- Status
- UNKNOWN
- Phase
- PHASE3
Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHD
- Status
- COMPLETED
- Phase
- PHASE2
Tocilizumab for Chronic Graft-versus-Host Disease Treatment
- Status
- WITHDRAWN
- Phase
- PHASE2
Prospective Outcomes of Second-Line Therapy in Acute Graft-Versus-Host Study Including ECP (POSTAGE)
- Status
- TERMINATED
- Phase
- N/A
Lactobacillus Rhamnosus GG in Reducing Incidence of Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- NA
Low-Dose Total Lymphoid Irradiation in Treating Patients With Refractory Chronic Graft-versus-Host Disease After Donor Stem Cell Transplant
- Status
- TERMINATED
- Phase
- NA
Phase I Trial of LDE225 for Steroid-refractory Chronic GVHD After Allogeneic HSCT
- Status
- TERMINATED
- Phase
- PHASE1
Lymphocyte Profiles and Activation Status in Patients With Graft-Versus-Host Disease
- Status
- WITHDRAWN
- Phase
- N/A
Phase 1 Infused Donor T Regulatory Cells in Steroid Dependent/Refractory Chronic GVHD
- Status
- COMPLETED
- Phase
- PHASE1
G-CSF Moblized Peripheral Harvest for Poor Engraftment After Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- NA
T&B Depletion Non Malignant
- Status
- UNKNOWN
- Phase
- PHASE2
Ex-vivo Expanded Donor Regulatory T Cells for Prevention of Acute Graft-Versus-Host Disease
- Status
- COMPLETED
- Phase
- PHASE1
Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib in Patients With Chronic Graft Versus Host Disease
- Status
- COMPLETED
- Phase
- PHASE1
Brentuximab Vedotin in Treating Patients With Steroid-Resistant Acute Graft-Versus-Host Disease
- Status
- WITHDRAWN
- Phase
- PHASE2
Bandage Lenses in Treating Patients With Ocular Graft-Versus-Host Disease
- Status
- COMPLETED
- Phase
- PHASE2